Background. Depending on both membrane composition and solute transport rate across the membrane, protein composition of the dialysate of patients receiving peritoneal dialysis (PD) has recently become of great interest. Unfortunately, thus far few studies have focused on dialysate characterization, and further investigations are required to better understand the biological mechanisms influencing PD efficiency. Methods. Different classical proteomic approaches were combined with advanced mass spectrometric (MS) techniques to analyse peritoneal fluid (PF) protein composition of adult patients receiving PD. Characterization was performed by using 1D gel electrophoresis combined with nano-RP-HPLC-ESI-MS/MS and shotgun proteomics, while comparative analyses were performed coupling 2D gel electrophoresis with MALDI-TOF MS. Results. The study allowed the identification of 151 different proteins from PF, which are mainly of plasmatic origin. Comparison of PD effluents characterized by different glucose concentrations demonstrated four proteins (apolipoprotein A-IV, fibrinogen beta chain, transthyretin and alpha-1-antitrypsin) to be under-expressed in the highest osmolar solution having 4.25% compared to others having 1.5% and 2.5% glucose. All of them were found to be involved in the inflammatory processes. Conclusions. This study provides a possible platform for future diagnostic and therapeutic applications in the field of PD and allowed the identification of potential targets to be used in preventing inflammatory processes induced by the exposure to dialysis solutions.
Introduction
Peritoneal dialysis (PD) is a method of renal replacement therapy used in~12% of dialysis patients worldwide in turn of haemodialysis (HD) to restore the composition of the body's fluid environment back to normal. Solute transport rate across the peritoneal membrane (peritoneal solute transport rate or PSTR) determines dialysis prescription and is also the major predictor of patient survival. From a molecular point of view, PSTR mainly depends upon (i) the effective surface area, (ii) the presence of pores like aquaporins in the peritoneal membrane [9] and (iii) the regulation of different growth factors like the vascular endothelial growth factor (VEGF), cytokines like interleukin 6 (IL-6) and small molecules like nitric oxide (NO) released by endothelial cells [11, 17, 19, 21, 33] . Recently, Pecoits-Filho and colleagues analysed plasma and dialysate levels of both IL-6 and VEGF in continuous ambulatory PD patients and correlated high plasma and dialysate concentration of IL-6 and VEGF with increased peritoneal transport rate of solutes, thus suggesting a link between inflammation, angiogenesis and PSTR [21] . Also, genetic variants together with clinical factors could contribute to the variability in the peritoneal transport at baseline: modulation of IL-6 gene expression seems to regulate systemic and local inflammation and, in association with comorbidity and uraemia, to affect the transport of small solutes across the peritoneal membrane [12] .
Unfortunately, in spite of all the studies conducted for the comprehension of the complex molecular mechanisms hiding behind the filtration process, thus far a comprehensive analysis of the PD effluents (PDEs) from adult patients is still missing, and therefore little is known about the overall peritoneal fluid protein composition [6] . Clinical proteomics has already proved its great potential enabling considerable progress to be made in cataloging and quantifying proteins in urine, plasma [1, 2] , haemodialysis fluids [13] and various kidney tissue compartments [3] . Therefore, proteomics is also a very suitable platform for the characterization of the proteins expressed in PDEs. Indeed, recently, classical proteomic approaches have been used in order to (i) analyse the dialysate protein profile of children treated by PD [23] , (ii) identify proteins pos-sibly involved in transport efficiency across the peritoneal membrane [30] , (iii) study the effects caused by peritonitis on PD fluids [15] and (iv) characterize diabetic peritoneal dialysate versus normal peritoneal fluid [31] .
Here we report the first complete characterization of PDE protein profile from adult patients suffering from end-stage renal diseases (ESRD) treated by dialysis, combining a classical proteomic approach based on LC-ESI-MS/MS analysis of 1D gel bands with shotgun proteomics. Furthermore, we performed 2D gel-based comparative analyses in order to better understand local peritoneal processes occurring at different solution osmolarities.
Materials and methods

Patients
A population of 15 uraemic Caucasian men and women (range 30-67 years old) affected by ESRD in treatment with PD was recruited. All subjects were unrelated and had been peritonitis-free for at least 3 months before the study, which was carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association. The ethical committee of the Second University of Naples approved the study protocol, and informed consent was obtained from all patients. Patients' clinical data, age, gender, duration of chronic peritoneal dialysis (CPD) therapy and numbers of peritonitis episodes were reviewed and recorded ( Table 1 ). The dialysate fluid containing (mEq/L) Na + 132, Ca 2 + 3.5, Mg 2 + 0.5, Cl − 95, lactate 40 and 1.5% glucose was used throughout the study (Baxter, Deerfield, IL, USA) except for the comparative analysis of solutions at different osmolarities where glucose concentration increased until 2.5% (osmolarity 395 mOsmol/L) and 4.25% (osmolarity 483 mOsmol/L).
Sample collection and preparation
Fifty millilitres of peritoneal fluid drained from each patient was added to 250 μL of protease inhibitor cocktail (Sigma Aldrich, St. Louis, MO, USA) and was immediately frozen at −80°C until use. Proteins were concentrated by using centrifugal concentrators, precipitated with a mixture of cold methanol and acetone (ratio 1:1) and solubilized with 7 M urea, 2 M thiourea, 4% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) and 100 mM dithiothreitol (DTT). Protein concentration was determined using Bradford's method [5] .
1D gel-based proteomic identification of PDE proteins PDE proteins extracted from each patient were pooled together and 20 μg of the sample was loaded on 10% polyacrylamide gradient gel according to Laemmli [14] . Gels were fixed and stained with Coomassie Brilliant Blue G-250. Selected gel bands were cut manually and placed into Eppendorf tubes. Reduction, alkylation and enzymatic hydrolysis with trypsin of proteins extracted from gel bands were performed according to Shevchenco [29] . Analysis of tryptic digests was performed on a QTOF instrument (Waters, Milford, MA, USA) equipped with a nanoflow electrospray ion source. Samples were loaded, purified and concentrated on a pre-column (PepMap, C18, 5-mm length, 300 Å; LCPackings, Sunnyvale, CA, USA) at a flow rate of 20 μL/min. Peptides were separated on a capillary column (PepMap, C18, 15-cm length, 75 μm ID, 300 Å; LCPackings) using a CapLC micro-HPLC. Eluents A [2% acetonitrile in 0.1% formic acid (HCOOH)] and B (95% acetonitrile in 0.1% HCOOH) were used. Separation was performed by a linear gradient: 2-60% B in 30 min and 60-95% B in 2 min. Collision-induced dissociation (CID) was used to generate peptide fragments from multiply charged molecular ions. Proteins were identified by MS/MS automated database searching (Mascot; Matrix Science, London, UK) against the Human IPI (International Protein Index) protein sequence database. Criteria for database searches were as follows: type of search, MS/MS Ion Search; enzyme, trypsin; number of missed cleavages allowed, two; fixed modifications, carbamidomethylation on cysteine residues; variable modifications, oxidation on methionine; and mass values, monoisotopic. Mass tolerances for protein identification were 100 p.p.m. for MS peaks and 0.3 Da for MS/MS peaks. False discovery rate was set at 0.05 for peptides and 0.01 for proteins. Only proteins identified by at least two peptides were accepted.
Shotgun proteomics of PDE proteins
Ten micrograms of the pooled PDE proteins were reduced with 5 mM Tris (2-carboxyethyl) phosphine and heated at 50°C for 1 h. Free cysteine residues were prevented to re-form disulphide bonds by labelling with the alkylating agent (iodacetamide) for 2 h at 37°C in the dark. Before adding trypsin, samples were diluted to final concentrations of 1.2 M urea. Nano-HPLC separation of peptide mixtures was performed using an Integral 100Q HPLC system (PerSeptive Biosystems, Framingham, MA, USA). Flow rate was split from 400 μL/min to 200 nL/min using a flow splitter (Accurate; LCPackings). The following eluents were used: 5% acetonitrile in 0.08% HCOOH and 0.01% trifluoroacetic acid (TFA) (A) and 95% acetonitrile in 0.08% HCOOH and 0.01% TFA (B). Gradient was 5-50% B in 190 min and 50-100% B in 5 min. One microgram of digested sample was loaded, purified and concentrated on a pre-column (PepMap, C18, 5-mm length, 300 Å) using an external Phoenix HPLC pump (Fisons Instruments, Manchester, UK) at a flow rate of 20 μL/min. Peptides were separated on a capillary column (PepMap, C18, 15-cm length, 75 μm ID, Patients treated with solutions differing in osmolarity (1.5, 2.5 and 4.25%).
Proteomic analysis of peritoneal fluid of patients treated by PD 1991 300 Å). For ESI-MS and MS/MS analysis, a QTOF type mass spectrometer (QStar-Pulsar; Applied Biosystems, Foster City, CA, USA) equipped with a nanoflow electrospray ion source fitted with pulled uncoated silica capillary was employed. Experiments were performed in informationdependent analysis (IDA) mode. Proteins were identified via automated database searching (Mascot; Matrix Science, London, UK) of all tandem mass spectra against the Human IPI protein sequence database. Criteria were the same as used in the 1D gel-based proteomics section.
Enrichment analysis of GO categories
We used Biological Networks Gene Ontology (BiNGO) program package [16] with the Cytoscape plugin to find statistically over-or underrepresented Gene Ontology (GO) categories [4] in biologic data as the tool for enrichment analysis of our PDE proteome dataset. For enrichment analysis, we needed a test dataset (PDE proteome) and a reference set of GO annotations for the complete human proteome. As per instructions on the BiNGO webpage, the custom GO annotations for the reference set (of whole IPI human dataset) were created by extracting the GO annotations available for Human IPI IDs from EBI GOA Human 39.0 release [32] . The GOA Human 39.0 release contains annotations for 28 873 proteins compiled from different sources. The analysis was done using 'hyper geometric test', and all GO terms that were significant with P <0.001 (after correcting for multiple term testing by Benjamini and Hochberg false discovery rate corrections) were selected as over-represented and under-represented.
2D gel-based comparative analyses of PDE protein patterns of solution at different osmolarity
Samples were grouped by glucose percentage of peritoneal dialysis solutions (1.5, 2.5 and 4.25%). 2D gel electrophoresis was performed as described by O'Farrell [20] . Briefly, 100 μg of proteins extracted from each patient was dissolved in rehydration solution (8 M urea, 2% CHAPS, 18 mM DTT, 0.5% v/v IPG buffer pH 3-10 and 0.002% bromophenol blue) and applied by in-gel rehydration in IPG strip (7 cm, pH 3-10) for 12 h. After isoelectrofocusing, proteins were reduced and alkylated by soaking the IPG strips in the equilibration solution (6 M urea, 2% SDS, 30% glycerol, 50 mM Tris-HCl, pH 8.8) containing, respectively, 130 mM DTT for 10 min at RT and 130 mM iodacetamide for 5 min. The equilibrated strips were sealed on top of a 10% SDS-PAGE gel. The 2D PAGE protein patterns were recorded as digitized images using a high-resolution scanner (GS-710 Calibrated Imaging Densitometer; Bio-Rad). Spot detection and analysis were performed using the PDQuest™ 2-D Analysis Software (Bio-Rad). Reduction, alkylation and enzymatic hydrolysis with trypsin of proteins from gel spots were performed as previously described for 1D gel bands. Samples were loaded onto MALDI target using 1 μL of the tryptic digests mixture, 1:1 ratio with a solution of the matrix CHCA (2 mg/mL in 50% ACN, 0.2% v/v TFA). A MALDI-TOF (matrix-assisted laser desorption ionization time of flight) instrument (M@LDI, Micromass) was used for the analysis. MassLynx 4.0 software was used for data processing and peak list generation. Peak lists containing the 40 most intense peaks of the spectrum were submitted to MASCOT PMF search engine (http://www. matrixscience.com) against human SwissProt database. Database search was performed assuming that peptides were monoisotopic, carbamidomethylated at cysteine residues and variably oxidized at methionine residues. Two missed cleavages were allowed and peptide mass tolerance of 100 p.p.m. was used for peptide mass fingerprinting.
Results
Protein characterization of PDEs by SDS-PAGE and shotgun proteomics
Protein characterization of peritoneal fluid was performed using two different bottom-up proteomic approaches, i.e. traditional 1D gel electrophoresis combined with nano-HPLC-ESI-MS/MS and shotgun proteomics. Starting from the top, gel was sliced into 12 consecutive blocks subsequently subjected to in-gel trypsinization and analysed by nanospray LC-MS/MS. From each of 12 blocks, analysis allowed the detection of multiple proteins for an overall number of 139 identifications. On the contrary, direct analysis of the tryptic mixture allowed the identification of 73 different proteins. Combining results obtained from the two proteomic approaches, the final of 151 non-redundant identifications was reached (Table 2) . 
Continued
Proteomic analysis of peritoneal fluid of patients treated by PD 1993 The identified proteins were categorized based on universal Gene Ontology (GO) annotation terms using BiNGO program package. In total, 108, 99 and 102 proteins were linked to at least one annotation term within, respectively, the GO cellular component, molecular function and biological process categories, exhibiting significance (P < 0.001) as over-represented terms compared with the entire list of IPI entries. As described in Figure 1 , in the cellular component category, GO terms related to extracellular environment such as extracellular region IPI Human was used as database source. Fig. 1 . Significantly over-represented GO cellular component terms for the set of identified PDE proteins. The set of identified PDE proteins was compared with the entire list of IPI entries (IPI_HUMAN), and significantly over-represented GO terms (P < 0.001) are shown. The ratio shown is the number of PDE and entire IPI proteins annotated to each GO term divided by the number of PDE and entire IPI proteins linked to at least one annotation term within the indicated GO cellular component, molecular function and biological process categories. GO, Gene Ontology; IPI, International Protein Index.
Proteomic analysis of peritoneal fluid of patients treated by PD 1995 (101 out of 108), extracellular region part (62 proteins) and extracellular space (57 proteins) were over-expressed in PDE dataset. Number in brackets refers to the number of proteins annotated to a certain term (for example extracellular region) in a given GO category (for example, cellular component). On the other hand, as during sample preparation procedure, PDEs were centrifuged and debris removed, GO terms related to intracellular proteins including cell (64), nucleus (8), integral to membrane (6) and organelle (36) are under-expressed (data not shown). Interestingly, GO term related to vesicles (19) and lipoprotein fraction (10) were also over-represented. Looking at molecular function and biological process categories, terms related respectively to protein binding ( Figure 2 ) and inflammatory processes ( Figure 3) were statistically over-represented.
Comparative proteomic analysis of PDE
A group of five uraemic patients was treated with three dialysis solutions differing for glucose concentration (1.5, 2.5 and 4.25%). Proteins were extracted according to the protocol described previously in the section 'Sample collection and preparation' and subsequently analysed by 2D electrophoresis for the comparative analyses. Our results revealed a significant (>2-fold change) quantitative deregulation of six different gel spots that were identified by MALDI-TOF MS as alpha-1-antitrypsin (spot 1603), fibrinogen beta chain (spots 4308-5303), transthyretin (spots 4303 and 2101) and apolipoprotein A-IV (spot 4208) (Table 3) . These proteins resulted under-expressed in the highest osmolar solution (glucose 4.25%) compared to the 1.5% and the 2.5% solutions (see Figure 4) . Interestingly, the intensity of the spot 2101 (corresponding to the monomeric form of the transthyretin) was observed to increase in proportion with the osmolarity of PF.
Discussion
PDE protein characterization
In this study, we report the f irst comprehensive characterization of protein profile from PDEs of adult patients affected by ESRD; 151 non-redundant proteins were identified and classified. Our analysis revealed that PDEs are enriched with extracellular proteins, in accordance with data obtained by Raaijmakers and colleagues on paediatric patients [23] . The presence of both gelsolin, a possible biomarker of the sepsis [10] , and intelectin, an adipocytokine possibly involved in the defence against intestinal bacterial permeation [28] , was also confirmed. Identifications also included a potassium voltage-gated channel (KCNQ2) and a voltage-dependent calcium channel, a multi-pass membrane protein that is thought to stabilize the calcium channel in its inactive state. No evidence for water channel aquaporin-1 (AQP1), the supposed molecular counterpart of the ultra-small pore predicted by the three-pore model of fluid transport across the peritoneal membrane [27] , was observed. The schematic representation of over-represented GO cellular component terms for our set of identified PDE proteins clearly demonstrates a significant enrichment of vesicle and lipoprotein particles (Figure 1 ), suggesting the presence of specific transport pathways occurring during PD. Also interesting are overrepresented GO biological process terms for our protein data set: 102 terms were enriched and most of them relate with inflammatory processes and immune response, thus highlighting the biological bio-incompatibility of dialysis solutions ( Figure 3) . Fig. 3 . Significantly over-represented GO biological process terms for the set of identified PDE proteins. Each term was selected as described in the legend to Figure 1 . GO, Gene Ontology. Protein names according to SwissProt database. Significance threshold P < 0.05. prot_acc, protein accession number; prot_desc, protein description; prot_matches, number of peptides matched; Score, mascot score; pep_exp_mr, expected peptide mass.
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Comparison of PD effluents characterized by different glucose 2D gel-based comparative analyses suggest that, even if the osmolarity of dialysis solutions does not influence the plasma protein qualitative composition, several quantitative differences can be detected. In particular, alpha-1-antitrypsin, fibrinogen beta chain, transthyretin and apolipoprotein A-IV resulted under-expressed in the highest osmolar solution (glucose 4.25%). Alpha 1 antitrypsin (1-PI) is known to belong to the family of serpins (serine protease inhibitors), the largest and most diverse family of protease inhibitors [7, 24] . This protein, produced from liver and monocytes [8] and differentially expressed in CPD patients with different types of membrane [30] , was proved to be biologically active in the PDEs in terms of inhibition of elastase activity and of synthesis of platelet-activating factor (PAF). The involvement of alpha 1-PI in the inflammation process was proved by Mariano and colleagues [18] who suggested that the absence of detectable amounts of PAF in peritonitis-free patients was due to the biological activity of alpha 1-PI. In addition, they also demonstrated that alpha 1-PI purified from patients with acute peritonitis is functionally inactive probably due to oxidative inactivation from inflammatory mediators during peritonitis [18] . All these data together indicate that, in the absence of inflammatory processes, antitrypsin biological activity inhibits the synthesis of the PAF, thus suppressing inflammatory response. On the contrary, when inflammation occurs, specific inflammatory mediators block antitrypsin, allowing PAF to be produced. This given, the lower expression of alpha 1-IP in highly osmotic solutions may be considered as a consequence of the higher inflammatory potential of 4.25% glucose solutions compared to 1.5 and 2.5% ones. Notably, also one of the chains of the fibrinogen, another protein involved in the inflammatory response, resulted under-expressed in the highly osmotic solutions. Fibrinogen is a hexamer (340 kDa) containing two sets of three different chains (α, β and γ) linked to each other by disulphide bonds. Its major function is as the precursor to fibrin, which is an insoluble material that forms blood clots. Briefly, processes in the coagulation cascade activate the zymogen prothrombin to the serine protease thrombin, which is responsible for converting fibrinogen β-chains into fibrinopeptide B (fibrin), a peptide of 14 amino acids that has been reported to have chemotactic activity for neutrophils (PMN) [26] . Therefore, the lower concentration of the precursor fibrinogen within the peritoneal fluid of patients treated by high osmolar solutions could be indicative of a higher degradation rate of the precursor in favour of the enzymatic product (the fibrin) directly involved into inflammatory events. Apolipoprotein A-IV and transthyretin, the other two under-regulated proteins, are transport proteins. While the biological function of apolipoprotein A-IV is still unclear, particularly interesting is the case of transthyretin (TTR), a homotetrameric carrier of the thyroid hormone thyroxine with a dimer of dimers configuration. Data analysis suggests that as solution osmolarity increases, the concentration of the mature protein goes down while its monomeric form becomes more concentrated. Such behaviour has been observed during fibril formation in amyloidogenic diseases; the mechanism by which the process of TTR amyloid fibril formation occurs in humans is not fully understood. In vitro biophysical experiments indicate that the process is likely to require the dissociation of the native tetramer into its constituent monomers [25] . Recent reports have stressed the importance of oligomeric intermediates as major cytotoxic species in various forms of amyloidogenesis: Reixach and colleagues examined the cytotoxic effects of several quaternary structural states of wild-type and variant TTR proteins on cells of neural lineage; they concluded that TTR amyloid fibrils and soluble aggregates >100 kDa were not toxic. On the contrary, incubation of TTR under the conditions of the cell assay and analysis by size-exclusion chromatography and SDS-PAGE revealed that monomeric TTR was the major cytotoxic species. Small molecules that stabilize the native tetrameric state were shown to prevent toxicity [22] . All these data together seem to suggest a direct involvement of TTR in inflammation process; in analogy with amyloid diseases, we suggest that an increase of glucose percentage within dialysis solutions could induce a transthyretin morphologic change. TTR passes from its tetrameric form to the monomeric one, thus stimulating cytotoxic activity.
